Patients’ Awareness of Advanced Disease Status,Psychological Distress and Quality of Life Among Patients With Advanced Cancer: Results From the APPROACH Study,India
Restricted accessResearch articleFirst published online July, 2022
Patients’ Awareness of Advanced Disease Status,Psychological Distress and Quality of Life Among Patients With Advanced Cancer: Results From the APPROACH Study,India
Prognostic disclosure to patients with advanced cancer facilitates treatment decisions and goals of care discussions. However, the perspectives of patients, families and physicians differ in this regard across different cultures. Non-disclosure of cancer diagnosis or prognosis is commonly observed in family-centric cultures such as India.
Aim:
To assess the prevalence of and factors associated with cancer patients’ awareness of advanced disease status; and its with quality of life and psychological distress.
Methods:
Patients for this cross-sectional questionnaire-based survey were recruited from oncology and palliative medicine clinics at a tertiary cancer hospital in India from January 2017 to June 2018. Patients aged ≥ 21 years, aware of cancer diagnosis and receiving oncology treatment for Stage IV solid cancer were included in the study after obtaining written informed consent.
Results:
Two hundred patients were enrolled, of which 146 (73%) were not aware of the stage of their malignancy and 9 (4.5%) believed that their disease was at stage I, II or III. Those who were aware of their advanced cancer stage had more years of education (9.9 years vs 8.1 years, p = .05) and had poorer spiritual wellbeing in the faith domain (adjusted difference −1.6, 95% confidence interval −3.1 to −0.1, p = .03) compared to those who were unaware.
Conclusion:
It is recommended that future studies may explore prognostic understanding in Indian patients according to their socio-cultural, spiritual and educational background.
TangSTChenCHWenFH, et al.Accurate prognostic awareness facilitates, whereas better quality of life and more anxiety symptoms hinder end-of-life care discussions: a longitudinal survey study in terminally ill cancer patients’ last six months of life. J Pain Symptom Manage. 2018;55(4):1068–1076.
2.
WenFHChenJSChouWCChangWCHsiehCHTangST. Factors predisposing terminally ill cancer patients’ preferences for distinct patterns/states of life-sustaining treatments over their last six months. J Pain Symptom Manage. 2019;57(2):190–198e2.
3.
FinlaysonCSChenYTFuMR. The impact of patients’ awareness of disease status on treatment preferences and quality of life among patients with metastatic cancer: a systematic review from 1997-2014. J Palliat Med. 2014;18(2):176–186.
4.
ApplebaumAJKolvaEAKulikowskiJR, et al.Conceptualizing prognostic awareness in advanced cancer: a systematic review. J Health Psychol. 2014;19(9):1103–1119.
5.
WrightAA. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14):1665.
6.
SutarRChandraPSSeshacharPGowdaLChaturvediSK. A qualitative study to assess collusion and psychological distress in cancer patients. Indian J Palliat Care. 2019;25(2):242–249.
7.
ChenCHKuoSCTangST. Current status of accurate prognostic awareness in advanced/terminally ill cancer patients: systematic review and meta-regression analysis. Palliat Med. 2017;31(5):406–418.
8.
CostantiniAGrassiLPicardiA, et al.Awareness of cancer, satisfaction with care, emotional distress, and adjustment to illness: an Italian multicenter study. Psychooncology. 2015;24(9):1088–1096.
9.
ChenJSWenFHChouWCHsiehCHChangWCTangST. Terminally ill cancer patients’ distinct symptom-functional patterns/states are differentially associated with their accurate prognostic awareness in the last six months of life. J Palliat Med. 2019;22(7):782–789.
10.
YanweiLDongyingLZhuchenYLingLYuZZhanyuP. A double-edged sword: should stage IV non-small cell lung cancer patients be informed of their cancer diagnosis?Eur J Cancer Care (Engl). 2017;26(6).
11.
NippRDGreerJAEl-JawahriA, et al.Coping and prognostic awareness in patients with advanced cancer. J Clin Oncol. 2017;35(22):2551–2557.
12.
GhoshalASalinsNDamaniA, et al.To tell or not to tell: exploring the preferences and attitudes of patients and family caregivers on disclosure of a cancer-related diagnosis and prognosis. J Glob Oncol. 2019;5:1–12.
13.
LaxmiSKhanJA. Does the cancer patient want to know? Results from a study in an Indian tertiary cancer center. South Asian J Cancer. 2013;2(2):57–61.
14.
HagertyRGButowPNEllisPM, et al.Communicating with realism and hope: incurable cancer patients’ views on the disclosure of prognosis. J Clin Oncol. 2005;23(6):1278–1288.
15.
KirkPKirkIKristjansonLJ. What do patients receiving palliative care for cancer and their families want to be told? A Canadian and Australian qualitative study. BMJ. 2004;328(7452):1343.
16.
MitchellAJ. Reluctance to disclose difficult diagnoses: a narrative review comparing communication by psychiatrists and oncologists. Support Care Cancer. 2007;15(7):819–828.
17.
HelftPR. Necessary collusion: prognostic communication with advanced cancer patients. J Clin Oncol. 2005;23(13):3146–3150.
18.
ChittemMMayaSChawakS. Nondisclosure of a cancer diagnosis and prognosis: recommendations for future research and practice. Indian J Cancer. 2021;58(2):158–164.
19.
KrishnaLAlsuwaighRMitiPWeiSLingKManoharanD. The influence of the family in conceptions of personhood in the palliative care setting in Singapore and its influence upon decision making. Am J Hosp Palliat Care. 2014;31(6):645–654.
20.
ChongJAQuahYLYangGMMenonSRadha KrishnaLK. Patient and family involvement in decision making for management of cancer patients at a centre in Singapore. BMJ Support Palliat Care. 2015;5(4):420–426.
21.
SankarSDDhanapalBShankarGKrishnarajBKarraSNatesanV. Desire for information and preference for participation in treatment decisions in patients with cancer presenting to the department of general surgery in a tertiary care hospital in India. J Glob Oncol. 2018;4:1–10.
22.
CellaDTulskyDGrayG, et al.The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–579.
23.
WebsterKCellaDYostK. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1:79.
24.
PetermanAHFitchettGBradyMJHernandezLCellaD. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy—spiritual well-being Scale (FACIT-Sp). Ann Behav Med. 2002;24(1):49–58.
25.
SnaithRP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29–29.
26.
SternAF. The hospital anxiety and depression scale. Occup Med (Lond). 2014;64(5):393–394.
27.
AnnunziataMAMuzzattiBAltoeG. Defining Hospital Anxiety and Depression Scale (HADS) structure by confirmatory factor analysis: a contribution to validation for oncological settings. Ann Oncol. 2011;22(10):2330–2333.
28.
BalharaYPSSagarR. Correlates of anxiety and depression among patients with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2011;15(5):50–54.
29.
ChaturvediSK. Ethical dilemmas in palliative care in traditional developing societies, with special reference to the Indian setting. J Med Ethics. 2008;34(8):611–615.
30.
JadhavSSukumarSKumarGBhatS. Prospective analysis of psychological distress in men being investigated for prostate cancer. Indian J Urol. 2010;26(4):490–493.
31.
KumarKKumarSMehrotraD, et al.Prospective evaluation of psychological burden in patients with oral cancer. Br J Oral Maxillofac Surg. 2018;56(10):918–924.
32.
AggarwalASinghNGuptaDBeheraD. Does awareness of diagnosis influence health related quality of life in north Indian patients with lung cancer?Indian J Med Res. 2016;143(7):38.
33.
MontazeriATavoliAMohagheghiMARoshanRTavoliZ. Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere?BMC Cancer. 2009;9:39.
34.
PapadopoulosAVrettosIKamposiorasK, et al.Impact of cancer patients’ disease awareness on their family members’ health-related quality of life: a cross-sectional survey. Psychooncology. 2011;20(3):294–301.
35.
KumarMGoyalSSinghK, et al.Breaking bad news issues: a survey among radiation oncologists. Indian J Palliat Care. 2009;15(1):61–66.
36.
BhatnagarSPatelA. Effectiveness of the certificate course in essentials of palliative care program on the knowledge in palliative care among the participants: a cross-sectional interventional study. Indian J Palliat Care. 2018;24(1):86–92.
37.
ChandraPSChaturvediSKKumarA, et al.Awareness of diagnosis and psychiatric morbidity among cancer patients—a study from South India. J Psychosom Res. 1998;45(3):257–261.
38.
LeeMKBaekSKKimSY, et al.Awareness of incurable cancer status and health-related quality of life among advanced cancer patients: a prospective cohort study. Palliat Med. 2013;27(2):144–154.
39.
TangSTLiuTWTsaiCMWangCHChangGCLiuLN. Patient awareness of prognosis, patient-family caregiver congruence on the preferred place of death, and caregiving burden of families contribute to the quality of life for terminally ill cancer patients in Taiwan. Psychooncology. 2008;17(12):1202–1209.
40.
GhandourhWA. Palliative care in cancer: managing patients’ expectations. J Med Radiat Sci. 2016;63(4):242–257.
41.
GielenJBhatnagarSChaturvediSK. Spirituality as an ethical challenge in Indian palliative care: a systematic review. Palliat Support Care. 2016;14(5):561–582.
42.
RegoFGonçalvesFMoutinhoSCastroLNunesR. The influence of spirituality on decision-making in palliative care outpatients: a cross-sectional study. BMC Palliat Care. 2020;19(1):22.
43.
GielenJBhatnagarSChaturvediSK. Prevalence and nature of spiritual distress among palliative care patients in India. J Relig Health. 2017;56(2):530–544.
44.
BackALTrinidadSBHopleyEKArnoldRMBaileWFEdwardsKA. What patients value when oncologists give news of cancer recurrence: commentary on specific moments in audio-recorded conversations. Oncologist. 2011;16(3):342–350.
